Literature DB >> 5451212

Clinical immunologic responsiveness in malignant disease. I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs.

M Al-Sarraf, P Wong, S Sardesai, V K Vaitkevicius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5451212     DOI： 10.1002/1097-0142(197008)26:2<262::aid-cncr2820260204>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Modulation of in vitro antitumor immunity in response to the biological activators interleukin-2, gamma interferon, and granulocyte monocyte-colony stimulating factor in the peripheral blood of cancer patients receiving cytotoxic chemotherapy.

Authors:  J E Harris; D P Braun
Journal:  Bull N Y Acad Med       Date:  1989-01

2.  Carcinoembryonic antigen in patients with urologic cancers.

Authors:  P Guinan; R J Ablin; H Barakat; T John; N Sadoughi; I M Bush
Journal:  Urol Res       Date:  1973-10

3.  Immune response and non-specific immunotherapy in melanoma.

Authors:  A A El-Domeiri
Journal:  Ann R Coll Surg Engl       Date:  1978-03       Impact factor: 1.891

4.  Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.

Authors:  W Weber; H P Missmahl; B Mazloumi
Journal:  Klin Wochenschr       Date:  1978-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.